Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of 7-day Triple, 10-day Sequential, and 7-day Concomitant Therapies for Helicobacter Pylori Infection in Taiwan
Brief Summary: To simultaneously compare the efficacies of 7-day triple, 10-day sequential and 7-day quadruple therapies for H. pylori infection in Taiwan. Consecutive H. pylori-infected patients were randomly assigned to a 7-day standard triple therapy (pantoprazole, clarithromycin, and amoxicillin for 7 days), a 10-day sequential therapy (pantoprazole and amoxicillin for 5 days, followed by pantoprazole, clarithromycin and metronidazole for a further 5 days) or a 7-day quadruple therapy (pantoprazole, clarithromycin, amoxicillin and metronidazole for 7 days). The end point is to evaluate the effectiveness of Helicobacter pylori eradication rates between three groups.


Options:
A: Arm Label: triple therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: 10 day triple therapy | Arm Label: Concomitant therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: 10 day sequential therapy | Arm Label: sequential therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: 10 day concomitant therapy | Intervention Type: DRUG; Name: 10 day triple therapy; Assigned to Arm(s): triple therapy | Intervention Type: DRUG; Name: 10 day sequential therapy; Assigned to Arm(s): Concomitant therapy | Intervention Type: DRUG; Name: 10 day concomitant therapy; Assigned to Arm(s): sequential therapy
B: Arm Label: AOC group; Type: EXPERIMENTAL; Interventions: Drug: amoxicillin, clarithromycin, metronidazole, rabeprazole | Arm Label: AOM group; Type: EXPERIMENTAL; Interventions: Drug: amoxicillin, clarithromycin, metronidazole, rabeprazole | Arm Label: Sequential group; Type: EXPERIMENTAL; Interventions: Drug: amoxicillin, clarithromycin, metronidazole, rabeprazole | Arm Label: concomitant group; Type: EXPERIMENTAL; Interventions: Drug: amoxicillin, clarithromycin, metronidazole, rabeprazole | Intervention Type: DRUG; Name: amoxicillin, clarithromycin, metronidazole, rabeprazole; Assigned to Arm(s): AOC group, AOM group, Sequential group, concomitant group
C: Arm Label: 7-day quadruple therapy; Type: EXPERIMENTAL; Interventions: Drug: 7-day quadruple therapy | Arm Label: 10-day sequential therapy; Type: EXPERIMENTAL; Interventions: Drug: 10-day sequential therapy | Arm Label: 7-day standard triple therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: 7-day standard triple therapy | Intervention Type: DRUG; Name: 7-day quadruple therapy; Assigned to Arm(s): 7-day quadruple therapy | Intervention Type: DRUG; Name: 10-day sequential therapy; Assigned to Arm(s): 10-day sequential therapy | Intervention Type: DRUG; Name: 7-day standard triple therapy; Assigned to Arm(s): 7-day standard triple therapy
D: Arm Label: Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: PACx14 | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: PACMx5 | Arm Label: Arm 3; Type: EXPERIMENTAL; Interventions: Drug: PAx5/PCMx5 | Intervention Type: DRUG; Name: PACx14; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: PACMx5; Assigned to Arm(s): Arm 2 | Intervention Type: DRUG; Name: PAx5/PCMx5; Assigned to Arm(s): Arm 3

Answer: C